Skip to Content

AdvisorShares Alpha DNA Eq Sntmnt ETF SENT

Medalist Rating as of | See AdvisorShares Investment Hub

Morningstar’s Analysis SENT

Will SENT outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in AdvisorShares Alpha DNA Eq Sntmnt ETF's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SENT

  • Current Portfolio Date
  • Equity Holdings 103
  • Bond Holdings 0
  • Other Holdings 2
  • % Assets in Top 10 Holdings 11.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Iwm Us 11/17/23 P182

2.50
371,572
1.08
160,523
Healthcare
1.08
160,280
Healthcare
1.04
154,734
Healthcare
1.03
153,109
Healthcare
1.02
150,928
Healthcare
1.00
148,065
Technology
0.99
146,819
Healthcare
0.99
146,803
Healthcare
0.99
146,406
Technology